Quantcast

Latest Merck Research Laboratories Stories

2015-01-26 23:01:38

SITC-Merck Cancer Immunotherapy Clinical Fellowship Award to Grant Young Investigator $100,000 to Advance the Field Milwaukee, WI (PRWEB) January 26, 2015

2014-12-06 12:21:53

Overall Response Rate of 66 Percent Observed in Pembrolizumab-treated Patients Whose Cancer Progressed on Brentuximab Vedotin Phase 2 Study Planned for the First Half of 2015

2014-06-23 20:21:23

Agreement to fund development of compounds for cognitive impairment associated with Alzheimer's disease and other conditions of the central nervous system SAN DIEGO,

2014-06-02 08:31:38

CAMBRIDGE, Mass., June 2, 2014 /PRNewswire/ -- Seres Health, a clinical-stage therapeutics company developing novel products to treat a host of disease conditions based on scientific findings

2014-05-08 12:29:33

WUPPERTAL, Germany and WHITEHOUSE STATION, New Jersey, May 8, 2014 /PRNewswire/ -- AiCuris and Merck (NYSE: MRK), known as MSD outside the United States and Canada, today